Drug Trial Radar · NCT06505941
Clinical Study on the Safety and Preliminary Efficacy of hUC-MSCs Intravenous Infusion Therapy for ARDS
Last checked: Nov 19, 2026Latest source record: Jul 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 20, 2024
Primary completion
Nov 20, 2025
Study completion Feb 20, 2027
Sponsor
- Lead sponsor
- Southeast University, ChinaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Zhongda Hospital; Yinguan Biologics, Shenzheng
- First posted
- Jul 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The object of this study is to observe the safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome, consisting with two phases.
Conditions
- Acute Respiratory Distress Syndrome
Interventions
umbilical cord mesenchymal stem cellDrug
umbilical cord mesenchymal stem cell
PlaceboDrug
non-cell-containing placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- The safety of umbilical cord mesenchymal stem cell therapy for acute respiratory distress syndrome.Time frame: The 1, 6, 24 hours; 3、7、14、21 days and 4, 12, 24, 36, 48 weeks after injection.
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.